NDC 0268-0852

CHAETOMIUM GLOBOSUM

Chaetomium Globosum

CHAETOMIUM GLOBOSUM is a Subcutaneous Injection, Solution in the Non-standardized Allergenic category. It is labeled and distributed by Alk-abello, Inc.. The primary component is Chaetomium Globosum.

Product ID0268-0852_152accc2-8563-4b11-9c7c-f61b002b30f8
NDC0268-0852
Product TypeNon-standardized Allergenic
Proprietary NameCHAETOMIUM GLOBOSUM
Generic NameChaetomium Globosum
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date1965-01-01
Marketing End Date2021-11-30
Marketing CategoryBLA / BLA
Application NumberBLA103753
Labeler NameALK-Abello, Inc.
Substance NameCHAETOMIUM GLOBOSUM
Active Ingredient Strength40000 [PNU]/mL
Pharm ClassesNon-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS]
NDC Exclude FlagN

Packaging

NDC 0268-0852-10

10 mL in 1 VIAL, MULTI-DOSE (0268-0852-10)
Marketing Start Date1965-01-01
Marketing End Date2021-11-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0268-0852-10 [00268085210]

CHAETOMIUM GLOBOSUM INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA103753
Product TypeNON-STANDARDIZED ALLERGENIC
Marketing Start Date1965-01-01

NDC 0268-0852-50 [00268085250]

CHAETOMIUM GLOBOSUM INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA103753
Product TypeNON-STANDARDIZED ALLERGENIC
Marketing Start Date1965-01-01

Drug Details

Active Ingredients

IngredientStrength
CHAETOMIUM GLOBOSUM40000 [PNU]/mL

Pharmacological Class

  • Non-Standardized Fungal Allergenic Extract [EPC]
  • Increased Histamine Release [PE]
  • Cell-mediated Immunity [PE]
  • Increased IgG Production [PE]
  • Fungal Proteins [CS]
  • Allergens [CS]